SCHEMBL351180

SCHEMBL351180

NC(=O)c1csc2c1CCNC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.43
MAPK8 P45983 1/20 0.42
CSNK1A1 P48729 1/20 0.42
LIMK1 P53667 1/20 0.42
MAP2K1 Q02750 1/20 0.42
PRKAA1 Q13131 1/20 0.42
DYRK1A Q13627 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
ADORA1 P30542 2/20 0.40
PARP1 P09874 7/20 0.39
PARP2 Q9UGN5 7/20 0.39
APEX1 P27695 1/20 0.38
HPGD P15428 1/20 0.36
PTPRC P08575 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
NNMT P40261 2/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16961478 0.98 PNMT (0.42) PNMTMAPK8CSNK1A1LIMK1MAP2K1
SCHEMBL31707285 0.87 PNMT (0.46) PNMTMAPK8CSNK1A1LIMK1MAP2K1
SCHEMBL3715448 0.85 PTPRC (0.42) PNMTMAPK8CSNK1A1LIMK1PRKAA1
SCHEMBL25363152 0.83 APEX1 (0.38) PNMTADORA1PARP1PARP2APEX1
Hydrochloric Acid SCHEMBL27077080 0.78 ADORA1 (0.44) LIMK1DYRK1ACLK4DYRK1BADORA1
Trifluoroacetic Acid SCHEMBL30055363 0.77 PTPRC (0.37) MAPK8CSNK1A1LIMK1PRKAA1DYRK1A
SCHEMBL6318336 0.76 ADORA1 (0.59) ADORA1HPGDMEN1ALDH1A1MAPT
SCHEMBL1292074 0.76 MAPK1 (0.45) HPGDALDH1A1MAPTMAPK1KMT2A
SCHEMBL6408001 0.75 HPGD (0.54) HPGDMEN1ALDH1A1MAPTMAPK1
SCHEMBL3121683 0.75 HPGD (0.58) HPGDMEN1ALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119161358-B 4,5,6, 7-Tetrahydrothiophene [2,3-c ] pyridine-3-carboxamide compound and preparation method and application thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 CN claimed
EP-4313994-B1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARM SPA (IT) 2025-03-05 EP claimed
CN-119161358-A 4,5,6, 7-Tetrahydrothiophene [2,3-c ] pyridine-3-carboxamide compound and preparation method and application thereof 沈阳药科大学 2024-12-20 CN claimed
EP-4313293-A1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2024-02-07 EP claimed
CN-117098764-A Tetrahydrothienopyridine derivatives as DDR inhibitors 奇斯药制品公司 2023-11-21 CN claimed
WO-2022200580-A1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-09-29 WO claimed
CN-119161358-B 4,5,6, 7-Tetrahydrothiophene [2,3-c ] pyridine-3-carboxamide compound and preparation method and application thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 CN disclosed
CN-119161358-B 4,5,6, 7-Tetrahydrothiophene [2,3-c ] pyridine-3-carboxamide compound and preparation method and application thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2026-05-26 CN disclosed
EP-4313293-B1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARM SPA (IT) 2025-05-07 EP disclosed
EP-4506349-A2 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2025-02-12 EP disclosed
CN-119161358-A 4,5,6, 7-Tetrahydrothiophene [2,3-c ] pyridine-3-carboxamide compound and preparation method and application thereof 沈阳药科大学 2024-12-20 CN disclosed
CN-119161358-A 4,5,6, 7-Tetrahydrothiophene [2,3-c ] pyridine-3-carboxamide compound and preparation method and application thereof 沈阳药科大学 2024-12-20 CN disclosed
US-20240391936-A1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-11-28 US disclosed
EP-2997367-A1 METHOD TO IDENTIFY COMPOUNDS ABLE TO BIND TO THE ROSSMANN FOLD OF C-TERMINAL-BINDING PROTEINS, IDENTIFIED COMPOUNDS AND MEDICAL USES THEREOF Consiglio Nazionale Delle Ricerche (IT) 2016-03-23 EP disclosed
WO-2014184370-A1 METHOD TO IDENTIFY COMPOUNDS ABLE TO BIND TO THE ROSSMANN FOLD OF C-TERMINAL-BINDING PROTEINS, IDENTIFIED COMPOUNDS AND MEDICAL USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2014-11-20 WO disclosed
US-8497283-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2013-07-30 US disclosed
US-20130023556-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-01-24 US disclosed
US-8329907-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2012-12-11 US disclosed
EP-2414346-A1 AUTOTAXIN INHIBITORS Merck Patent GmbH (DE) 2012-02-08 EP disclosed
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240391936-A1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS DDR1, DDR2, DDRGK1 PNMT 4126/4885MAPK8 998/4885CSNK1A1 258/4885
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 PNMT 2640/4885MAPK8 3052/4885CSNK1A1 2417/4885
US-20130023556-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 PNMT 2640/4885MAPK8 3052/4885CSNK1A1 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.